These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24350917)

  • 21. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
    Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
    Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma.
    Yang ZH; Liang WB; Jia J; Wei YS; Zhou B; Zhang L
    Acta Oncol; 2008; 47(3):379-84. PubMed ID: 17882560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array.
    Hu S; Qu Y; Xu X; Xu Q; Geng J; Xu J
    PLoS One; 2013; 8(9):e74161. PubMed ID: 24066112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy.
    Le Z; Niu X; Chen Y; Ou X; Zhao G; Liu Q; Tu W; Hu C; Kong L; Liu Y
    Oncotarget; 2017 Sep; 8(38):63026-63037. PubMed ID: 28968968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of intensity modulated radiation therapy on oral mucosa and immune function in patients with nasopharyngeal carcinoma].
    Liang S; Zhang N; Chen L; Zhang Y; Zheng Z; Luo W; Xu T; Lü Z; Li S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):505-510. PubMed ID: 29886466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
    Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
    Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of hematological inflammatory markers for severe oral mucositis in patients with nasopharyngeal carcinoma during intensity-modulated radiation therapy: A retrospective cohort study.
    Huang X; Qin X; Huang W; Huang B
    Curr Probl Cancer; 2024 Aug; 51():101117. PubMed ID: 38945022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
    Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
    Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
    Ren G; Du L; Ma L; Feng LC; Zhou GX; Qu BL; Xu SP; Xie CB; Ou GM; Li F; Zhang XX; Yang J
    Technol Cancer Res Treat; 2011 Jun; 10(3):259-66. PubMed ID: 21517132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association between MKK4 promoter-1304T/G polymorphism and genetic susceptibility in sporadic nasopharyngeal carcinoma].
    Lu M; Kong Q; Xu X; Lu H; Lu Z; Shi K; Xu B; Guo R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 30(4):287-90. PubMed ID: 27373035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Functional Polymorphisms of DNA Double-Strand Breaks in Repair Genes XRCC5, XRCC6 and XRCC7 with the Risk of Systemic Lupus Erythematosus in South East Iran.
    Jahantigh D; Salimi S; Mousavi M; Moossavi M; Mohammadoo-Khorasani M; Narooei-nejad M; Sandoughi M
    DNA Cell Biol; 2015 May; 34(5):360-6. PubMed ID: 25756210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KARP-1 works as a heterodimer with Ku70, but the function of KARP-1 cannot perfectly replace that of Ku80 in DSB repair.
    Koike M; Yutoku Y; Koike A
    Exp Cell Res; 2011 Oct; 317(16):2267-75. PubMed ID: 21756904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
    Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
    Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive effect of single nucleotide RAD51 135G>C polymorphism and low Ku70 protein expression on female rectal cancer patients survival after preoperative radiotherapy.
    Gasinska A; Biesaga B; Widla AJ; Darasz Z
    Turk J Gastroenterol; 2019 Jan; 30(1):3-14. PubMed ID: 30289394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities.
    Guo R; Tang LL; Mao YP; Zhou GQ; Qi ZY; Liu LZ; Lin AH; Liu MZ; Ma J; Sun Y
    PLoS One; 2015; 10(7):e0129679. PubMed ID: 26146828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy: an analysis of survival and treatment toxicities.
    Cao CN; Luo JW; Gao L; Yi JL; Huang XD; Wang K; Zhang SP; Qu Y; Li SY; Xiao JP; Zhang Z; Xu GZ
    Oral Oncol; 2015 Feb; 51(2):190-4. PubMed ID: 25434585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer.
    Sanguineti G; Sormani MP; Marur S; Gunn GB; Rao N; Cianchetti M; Ricchetti F; McNutt T; Wu B; Forastiere A
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):235-42. PubMed ID: 22104358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):28-34. PubMed ID: 26754263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.